- Business Wire•4 days agoTherapeuticsMD Announces Multiple Presentations Related to Yuvvexy™ (TX-004HR) at Two Upcoming Medical Conferences
TherapeuticsMD, Inc. , an innovative women’s healthcare company, today announced the schedule of nine posters and oral presentations at upcoming medical conferences related to Yuvvexy, the conditionally-approved trade name for TX-004HR, an investigational applicator-free vaginal estradiol softgel capsule in development for the treatment of moderate-to-severe vaginal pain during sexual intercourse , ...
- Business Wire•7 days agoTherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for Yuvvexy™ (TX-004HR)
TherapeuticsMD, Inc. , an innovative women’s healthcare company, today announced the acceptance of the NDA for Yuvvexy, the conditionally-approved trade name for TX-004HR, by the U.S.
TherapeuticsMD, Inc. (TXMD)
NYSE MKT - NYSE MKT Real Time Price. Currency in USD
|Bid||6.49 x 600|
|Ask||6.50 x 600|
|Day's Range||6.40 - 6.55|
|52wk Range||5.18 - 11.26|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-15.43|
|Avg Vol (3m)||1,277,866|
|Dividend & Yield||N/A (N/A)|